University of Calgary

Chang-Chun Ling

  • Associate Professor
  • Organic Chemistry

Currently Teaching

Research Interests

Our research interests are in the area of bioorganic chemistry. The main objective is to develop and apply modern synthetic carbohydrate chemistry and bioorganic chemistry to the understanding of carbohydrate-protein interactions involved in tumorigenesis, cancer metastasis and infection, and to the design, synthesis and immunological evaluation of microbial and tumor-associated mammalian carbohydrate antigens. Our research adopts a multidisciplinary approach by engaging modern carbohydrate chemistry, biochemistry and immunochemistry by making use of novel knowledge acquired from biology’s newest discoveries to guide the design and synthesis of inhibitor molecules capable of selectively interfering with the crucial biosynthetic pathways that cancer cells rely on to survive, spread and proliferate and to raise antibodies with high immunospecificity and immunoaffinity to prevent infectious disease.

Currently, our research is focused on the following four areas:

(1). Rational design and synthesis of inhibitors for tumor-associated glycosyltransferases

Glycosyltransferases are the primary gene products responsible for the biosynthesis of complex carbohydrates in living cells. Many human diseases are associated with abnormal glycosyltransferase activities which can lead to the over-expression or under-expression of carbohydrate structures. Since carbohydrates are the primary mediator molecules involved in all sorts of bio-recognition events, this can directly lead to the unusual behavior and biological functions of cells. With the help of computer modeling, we are actively involved in the design, synthesis and biological assaying of inhibitors for tumor-associated glycosyltransferases.

(2). Synthesis and immunological evaluation of neoglycoconjugates for the prevention of infectious diseases and cancer

The cell surface of many bacterial species is covered with polysaccharides. These extracellular carbohydrates can be in the form of glycolipids, glycoproteins or capsules. The capsular polysaccharides exist in both Gram-negative and Gram-negative bacteria such as Neisseria meningitidis, Haemophilus influenzae, E. coli, Streptococci pneumoniae etc. A special form of glycolipids is called lipopolysaccharides which exist only in Gram-negative bacteria. These polysaccharides are strain-specific and serve as virulence factors for the bacteria. Immune response against the cell surface polysaccharides can stimulate the hosts to produce strain-specific antibodies which can protect the hosts from future infections by the same bacterial strain. We are heavily involved in the synthesis and immunological evaluation of neoglycoconjugates related to some of the polysaccharides.

(3). The development of clustering methodologies to synthesize conjugate vaccines with enhanced immunogenicity

The surface of an immune B-lymphocyte is coated with thousands of receptors of single specificity. The binding and uptake of antigen molecules by B-cell receptors are crucial steps in humoral and cell-mediated immune responses. Clustering antigen molecules before presenting to B cells thus has the potential of increasing immunogenicity because this improves the binding to B-cell receptors through multivalent interactions. We are involved in developing efficient clustering methodologies to prepare conjugate vaccines with improved immunogenicity.

(4). Conformational analysis and molecular modeling of carbohydrates

The use of computer-aided conformational analysis and molecular modeling is an integrated part of our research. We rely on computers to help us to visualize and understand the molecular interactions involved in carbohydrate-protein recognitions and use the information to guide our design and synthesis of analogs with improved properties. We also carry out calculations in order to determine the conformation of carbohydrates and their analogs and correlate with crystallographic and NMR studies.

Students

Powered by UNITIS. More features.